Page last updated: 2024-08-25

acamprosate and Amyotrophic Lateral Sclerosis

acamprosate has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Boussicault, L; Callizot, N; Cohen, D; Hajj, R; Laffaire, J; Nabirotchkin, S; Rinaudo, P; Schmitt, P	1

Other Studies

1 other study(ies) available for acamprosate and Amyotrophic Lateral Sclerosis

Article	Year
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis. Journal of neuroscience research, 2020, Volume: 98, Issue:12 Topics: Acamprosate; Amyotrophic Lateral Sclerosis; Animals; Baclofen; Cell Survival; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Drug Therapy, Combination; Female; GABA-B Receptor Agonists; Motor Neurons; Pregnancy; Rats; Rats, Transgenic; Rats, Wistar	2020

Article

Year

Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.

Journal of neuroscience research, 2020, Volume: 98, Issue:12

Topics: Acamprosate; Amyotrophic Lateral Sclerosis; Animals; Baclofen; Cell Survival; Cells, Cultured; Cerebral Cortex; Coculture Techniques; Drug Therapy, Combination; Female; GABA-B Receptor Agonists; Motor Neurons; Pregnancy; Rats; Rats, Transgenic; Rats, Wistar

2020